Comparison of Short- and Long-term Efficacy and Safety Between Ticagrelor and Clopidogrel in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Phase of Trial: Phase IV
Latest Information Update: 21 Nov 2018
Price : $35 *
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 18 Sep 2018 New trial record
- 29 Aug 2018 Primary endpoint (composite of vascular death, myocardial infarction and stroke) has not been met, according to results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology.
- 29 Aug 2018 Interim results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology.